Janssen Pharmaceuticals Inc. - Raritan, United States - FDA Site Report

FEI Number: 2211100

Overview Statistics

Total Inspections

Total 483s Issued

Warning Letters Issued

20.0%

483 Issue Rate

Last Inspected: 2024-11-01

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Date	Investigators	Category	Days
2024-11-01	Xiuju Lu Kevin J Matthews Carl A Perez	Biologics	5 days
2023-12-14	Laurel A Beer Thai D Truong	Biologics	10 days
2022-06-17	Frederick Razzaghi	Human Drugs	17 days
2021-09-17	David E Bailey Jacqueline M Diaz Albert Lily Y Koo Graeme E Price Zhaohui Ye Jacqueline M Diaz Albertini	Biologics	5 days
2017-01-26	Paul L Bellamy	Human Drugs	4 days
2016-01-22	Michael Serrano	Human Drugs	9 days
2013-05-21	Michael Serrano	Human Drugs	6 days
2012-06-19	Paul L Bellamy	-	-
2011-08-22	Paul L Bellamy	-	-
2010-08-06	Atul Agrawal Paul L Bellamy	-	-

Last Updated: 2025-05-14 06:12:57